STATEMENT On $147M Verdict for AMDR Member Innovative Health Against Johnson & Johnson’s Biosense Webster Medical Technology Unit
[Washington, D.C. and Berlin, Germany / 18 May 2025] Friday’s unanimous verdict by a federal jury in Santa Ana, California for Innovative Health against Johnson & Johnson (NYSE: JNJ) is a victory for America’s hospitals,
Earth Day News: Hospitals and Surgical Centers in 17 Countries Partnered with AMDR Members to Save over $451M (€433M), Eliminate the Equivalent of over 115M Pounds (52M kg) of CO₂ Emissions, by Using Regulated, Reprocessed “Single-Use” Medical Devices in 2024
[Washington, DC / Berlin Germany – 22 April 2025] In commemoration of Earth Day, the Association of Medical Device Reprocessors and its members released the results of its 2024 member survey. Among the key findings
Position Paper: The Time Has Come To Change the “Opt-In” Provision of the EU MDR (Article 17)
The “Opt-In” Provision of the EU MDR (Article 17): Undermines EU Law and the Single Market Deprives Hospitals of Sustainable Medical Device Options, and Exacerbates Shortages in the Healthcare Supply Chain The time has come